Back to today’s briefing

Story perspectives

AI-Driven Gene Delivery Revolutionizes Neurological Disorder Treatments

5/22/2025

50 5

Summary

Story summary

NIH-funded researchers have unveiled groundbreaking gene delivery systems utilizing adeno-associated viruses (AAVs) to precisely target neural cells in the brain and spinal cord. This innovative toolkit, powered by AI to pinpoint gene enhancers, promises to revolutionize the treatment of neurological disorders such as ALS and Parkinson’s disease, paving the way for tailored gene therapies.

1 of 1

Story summary

NIH-funded researchers have unveiled groundbreaking gene delivery systems utilizing adeno-associated viruses (AAVs) to precisely target neural cells in the brain and spinal cord. This innovative toolkit, powered by AI to pinpoint gene enhancers, promises to revolutionize the treatment of neurological disorders such as ALS and Parkinson’s disease, paving the way for tailored gene therapies.